HSP90AB1 and cancer: The association of Hsp90 with a plethora of pathways including signal transduction, cell-cycle control, transcriptional regulation and many others [16-18] marks it as target for pharmacological modulation in a number of diseases, particularly for cancer, where the chaperoning of mutated and overexpressed oncoproteins is critical [19].